Investor Relations > FAQ

Frequently Asked Questions

Where is Protea located?

We are headquartered in Morgantown, WV where we occupy 20,000 square feet of office and laboratory space.

When was Protea founded?

Protea Biosciences, Inc. was founded in July 2001 and was founded as a Delaware "C" corporation. On September 2, 2011 we completed a merger with SKRP 5, also a Delaware corporation that was founded in May 2005. On September 2, 2011 Protea Biosciences, Inc. became the 100% wholly owned subsidiary of Protea Biosciences Group, Inc. Additional information about our history can be found through our past SEC filings.

Is Protea publically traded?

Yes, Protea's common stock became publicly traded on the OTCQB on April 11, 2014 under the symbol PRGB.

Where can I find Protea's SEC filings?

You can find all of our filings through the SEC Filings section of our investor relations web site and through the SEC's website.

When is Protea's fiscal year-end?

Our fiscal year-end is December 31.

Who are Protea's auditors?

Our auditors are Schneider Downs & Co., Inc.

What firm does Protea use as SEC legal counsel?

Our SEC legal counsel is Richardson & Patel LLP.

Who is Protea's transfer agent?

Island Stock Transfer. They can be reached directly at (727) 289-0010.

Where can I find additional information about Protea?

You can find additional information through the following sources:

Who can I contact if I have a question about Protea?

Please fill out the 'Contact Us' form and a member of our investor relations team will contact you as quickly as possible.
...innovations for bioanalytics